FLGT Fulgent Genetics, Inc.

12.67-0.14 (-1.09%)
Close: August 23, 2019

12.810.14 (+1.11%)
Pre-market

Quote

Previous Close
$12.67
Day Range
$12.16-$12.88
52 Week Range
$3.02-$12.88
Volume
106,093
Avg Volume
74,019
Dividend TTM
-
Ex-Dividend Date
-

Valuation

Market Cap
$234.22M
Enterprise Value (EV)
$205.77M
PE Ratio
-
EV/EBITDA
-70.78
Price/Sales
11.09
Price/Book
4.58
PEG Ratio
0.08

Financials

Revenue
$21.35M
Gross Profit
$10.65M
EBITDA
-$2.91M
EPS, ttm
-$0.23
Profit Margin
-
Revenue/Employee
$173.59K
Next Earnings Date
11/4/2019 (71 days)
Debt to Equity
-
Debt
$2.59M
Cash
$31.03M
Net Debt
-

Performance

Beta
0.62
200 Day Moving Avg
$5.53
50 Day Moving Avg
$7.66
52 Week Change
191.26%
YTD Change
262.99%
1 Month Change
105.02%
3 Month Change
117.70%
6 Month Change
177.07%
1 Year Change
191.26%
2 Year Change
-37.91%
5 Year Change
-27.56%

Share Count

Shares Outstanding
18.5M
Float
5.7M
Restricted Shares
12.8M
Restricted Shares, %
69.10%

Fulgent Genetics, Inc. Company Details

Sector: Health Services

Industry: Medical/Nursing Services

CEO: Ming Hsieh

Website: http://www.fulgentgenetics.com

Description: Fulgent Genetics, Inc. is a technology company, which focus on offering comprehensive genetic testing to provide physicians with clinically actionable diagnostic information they can use to improve the overall quality of patient care. Its technology platform includes proprietary gene probes, advanced database algorithms, adaptive learning software, and proprietary laboratory information management systems. The company was founded on May 13, 2016 and is headquartered in Temple City, CA.

Employees: 123